Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: transcranial direct current stimulator.
- Who it may be relevant to
- Registry conditions: Patellofemoral Pain Syndrome. Basic parameters: 18 years — 45 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain: a Randomized Control Trial
Overview
This study sought to investigate whether modulation of cortical excitability of the gluteal musculature, via tDCS paired with exercise, will reduce the amount the knee caves in during functional tasks in individuals with PFP. The objective is the explore if having tDCS target the area of the brain controlling hip muscles, when paired with exercise, will be more effective in reducing the amount the knee caves in for individuals with PFP versus those who receive exercise alone as their treatment. The aim is to contribute our findings to the growing knowledge in this area in order to help establish the possibility, and feasibility, of its use in clinical settings to strengthen traditional treatments for this patient population.
Interventions
- Device transcranial direct current stimulator
The total amount of participation time per qualified subject will be approximately 150 minutes over two sessions. The participant screening session will take approximately 30 minutes, which is an appropriate amount of time to complete all screening tasks. The tDCS and sham sessions will take approximately a total of 120 minutes over two sessions. The first session will include a screening (30 minutes) to ensure they qualify for the study, followed by a treatment session (60 minutes): including
Primary outcome measures
- trunk lean angle [Time frame: Baseline and Immediately after intervention]
- knee frontal plane projection angle [Time frame: Baseline and Immediately after intervention]
- hip frontal plane projection angle [Time frame: Baseline and Immediately after intervention]
- dynamic valgus index [Time frame: Baseline and Immediately after intervention]
Eligibility criteria
Inclusion criteria
- are between 18 and 45 years old
- have had patellofemoral pain (PFP; kneecap pain) on one side for at least 3 months, and 3) the knee does cave in when performing functional movements.
Exclusion criteria
- do not have pain coming from the kneecap during screening;
- have a history of knee injury or surgery,
- have a history of seizures and/or taking anti-seizure medication,
- have an implanted device that interacts with electric current,
- have a history of balance disorder,
- currently are pregnant or think they may be pregnant.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- University of Nevada, Las Vegas — Las Vegas
Identifiers
NCT: NCT06565520 · UNLV-2022-69